Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

86%

6 of 7 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06840236Completed

Digital Health Intervention On Awareness Of Vaccination Against Influenza Among Adults With Diabetes

Role: lead

NCT02053584Not ApplicableCompleted

Dario™ Blood Glucose Monitoring System - User Performance Evaluation

Role: lead

NCT02357043Not ApplicableCompleted

User Performance Evaluation for DARIO™ BGMS

Role: lead

NCT04057248Not ApplicableCompleted

Digital Self-Management and Health Coaching for Type 2 Diabetes - Impact on Diabetes Clinical and Wellness Indicators

Role: lead

NCT02910674Not ApplicableCompleted

Dario Blood Glucose Monitoring System - Android Devices User Performance Study Report

Role: lead

NCT02916563Not ApplicableCompleted

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

Role: lead

NCT02352298Not ApplicableCompleted

Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude

Role: lead

All 7 trials loaded